Hybrid Polyketide Synthase Library Generation via Three-Hybrid Selection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The discovery and development of small molecules and natural products that bind to protein targets, such as polyketides and non-ribosomal peptides, is a slow and expensive process due to limitations in producing effective diversity libraries and selecting for binding to variable protein targets within cellular systems.

Innovation Solution

A three-hybrid selection system is developed, utilizing recombination 'hotspots' to generate hybrid polyketide synthases and create libraries of cells producing polyketides that can bind to specific protein targets, enabling the selection of cells producing polyketides that activate a reporter gene when binding to target proteins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional in vitro screening methods are used to discover small molecules binding to protein targets, then binding activity can be tested, but the process is slow and expensive requiring large compound libraries

Engineering Contradiction:
Improvebinding activity detectionVSAvoiddiscovery and development time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces traditional in vitro mechanical screening systems with a biological cellular system. Instead of isolating compounds and testing them in test tubes, the invention uses cells that naturally produce polyketides and express target proteins, allowing binding detection to occur within the living cellular environment. This substitution enables parallel screening of multiple compounds simultaneously through cellular phenotypes, dramatically reducing time while maintaining detection capability

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a reporter gene system as an intermediary between the polyketide production and target protein binding detection. The reporter gene (such as antibiotic resistance genes) acts as a mediator that translates the binding event into a selectable phenotype. When polyketides bind to their target proteins within the cell, this interaction activates or maintains the reporter gene expression, enabling indirect but efficient detection of binding activity without direct in vitro testing

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If large diversity libraries are generated for screening, then the chance of finding active compounds increases, but the cost and complexity of the screening process increases significantly

Engineering Contradiction:
Improvelibrary diversityVSAvoidscreening system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent enables the cellular system to serve itself in producing and screening polyketides. The cells naturally produce diverse polyketide compounds through their endogenous polyketide synthase pathways and simultaneously express the target proteins and reporter genes needed for screening. This self-service capability eliminates the need for external compound synthesis and isolation steps, allowing high diversity libraries to be screened within the cellular system without proportionally increasing complexity

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent creates a universal cellular platform that can screen multiple different target proteins and polyketide variants using the same system architecture. The reporter gene system is designed to work with various target proteins, and the cellular host can produce diverse polyketides through genetic variation. This multi-functionality allows a single screening system to handle multiple targets and compounds, reducing overall complexity compared to dedicated screening systems for each target

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If directed evolution methods are applied to polyketides, then binding variants can be selected, but the breadth of molecules that can be selected is limited and significant screening effort is required

Engineering Contradiction:
Improvebinding variant diversityVSAvoidscreening efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent moves the screening process from a one-dimensional in vitro assay to a multi-dimensional cellular system. Instead of testing compounds in isolation, the invention incorporates binding detection within the cellular context where polyketides are produced, processed, and secreted naturally. This dimensional change allows simultaneous variation of multiple parameters (polyketide structure, target protein, cellular environment) to be screened in parallel, expanding the breadth of selectable molecules while improving efficiency through the natural cellular production pathway

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the generation of diverse polyketide libraries with increased productivity and efficiency, reducing costs and improving the chances of finding molecules that bind to target proteins, while maintaining the balance of the biosynthetic network.

Implementation Method 1

a three-hybrid selection system comprising: first and second elements which are proteins and a third element which is a natural product selected from polyketides and non-ribosomal peptides, wherein the first and second elements can bind the third element

Methodology Applied
Scientific EffectProtein-protein binding interaction:

Data Source

PatentUS11781128B2Methods for producing hybrid polyketide synthase genes and polyketides
Publication Date: 2023.10.10 ISOMERASE THERAPEUTICS
  • US11781128B2 patent drawing
  • US11781128B2 patent drawing
  • US11781128B2 patent drawing

AI summary

The present invention provides inter alia methods for generating a library of cells producing polyketides and selecting for these strains based on binding to a protein target.